nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—Blood creatinine increased—Cimetidine—obesity	0.0117	0.0309	CcSEcCtD
Azilsartan medoxomil—Hyperuricaemia—Sibutramine—obesity	0.00993	0.0262	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Sibutramine—obesity	0.00938	0.0247	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Methamphetamine—obesity	0.00893	0.0235	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Benzphetamine—obesity	0.00861	0.0227	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Methamphetamine—obesity	0.00708	0.0186	CcSEcCtD
Azilsartan medoxomil—Dizziness—Methamphetamine—obesity	0.00684	0.018	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Benzphetamine—obesity	0.00683	0.018	CcSEcCtD
Azilsartan medoxomil—Dizziness—Benzphetamine—obesity	0.0066	0.0174	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Phentermine—obesity	0.00642	0.0169	CcSEcCtD
Azilsartan medoxomil—Fatigue—Phentermine—obesity	0.00641	0.0169	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Sibutramine—obesity	0.00627	0.0165	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Phendimetrazine—obesity	0.00622	0.0164	CcSEcCtD
Azilsartan medoxomil—Dizziness—Phendimetrazine—obesity	0.00601	0.0158	CcSEcCtD
Azilsartan medoxomil—Nausea—Benzphetamine—obesity	0.00593	0.0156	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Diethylpropion—obesity	0.00558	0.0147	CcSEcCtD
Azilsartan medoxomil—Nausea—Phendimetrazine—obesity	0.0054	0.0142	CcSEcCtD
Azilsartan medoxomil—Asthenia—Phentermine—obesity	0.00533	0.014	CcSEcCtD
Azilsartan medoxomil—Fatigue—Cimetidine—obesity	0.00531	0.014	CcSEcCtD
Azilsartan medoxomil—Dizziness—Phenylpropanolamine—obesity	0.00514	0.0135	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Phentermine—obesity	0.00509	0.0134	CcSEcCtD
Azilsartan medoxomil—Telmisartan—PPARG—obesity	0.00497	0.598	CrCbGaD
Azilsartan medoxomil—Dizziness—Phentermine—obesity	0.00492	0.0129	CcSEcCtD
Azilsartan medoxomil—Rash—Phenylpropanolamine—obesity	0.0049	0.0129	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Phenylpropanolamine—obesity	0.00489	0.0129	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Orlistat—obesity	0.00471	0.0124	CcSEcCtD
Azilsartan medoxomil—Rash—Phentermine—obesity	0.00469	0.0123	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Phentermine—obesity	0.00468	0.0123	CcSEcCtD
Azilsartan medoxomil—Nausea—Phenylpropanolamine—obesity	0.00461	0.0121	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Sibutramine—obesity	0.00456	0.012	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Diethylpropion—obesity	0.00442	0.0117	CcSEcCtD
Azilsartan medoxomil—Nausea—Phentermine—obesity	0.00442	0.0116	CcSEcCtD
Azilsartan medoxomil—Asthenia—Cimetidine—obesity	0.00441	0.0116	CcSEcCtD
Azilsartan medoxomil—Dizziness—Diethylpropion—obesity	0.00428	0.0113	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Cimetidine—obesity	0.00421	0.0111	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Sibutramine—obesity	0.0042	0.0111	CcSEcCtD
Azilsartan medoxomil—Rash—Diethylpropion—obesity	0.00408	0.0107	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Diethylpropion—obesity	0.00407	0.0107	CcSEcCtD
Azilsartan medoxomil—Dizziness—Cimetidine—obesity	0.00407	0.0107	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Orlistat—obesity	0.004	0.0105	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Bupropion—obesity	0.00397	0.0105	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Bupropion—obesity	0.00396	0.0104	CcSEcCtD
Azilsartan medoxomil—Rash—Cimetidine—obesity	0.00388	0.0102	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Cimetidine—obesity	0.00388	0.0102	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Sibutramine—obesity	0.00387	0.0102	CcSEcCtD
Azilsartan medoxomil—Nausea—Diethylpropion—obesity	0.00384	0.0101	CcSEcCtD
Azilsartan medoxomil—Angioedema—Orlistat—obesity	0.0038	0.01	CcSEcCtD
Azilsartan medoxomil—Angioedema—Sibutramine—obesity	0.00368	0.00969	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Bupropion—obesity	0.00366	0.00964	CcSEcCtD
Azilsartan medoxomil—Nausea—Cimetidine—obesity	0.00365	0.00962	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00352	0.00927	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Topiramate—obesity	0.00348	0.00917	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Bupropion—obesity	0.00338	0.00889	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Orlistat—obesity	0.00333	0.00877	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Orlistat—obesity	0.0033	0.00869	CcSEcCtD
Azilsartan medoxomil—Angioedema—Bupropion—obesity	0.00321	0.00845	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Sibutramine—obesity	0.00319	0.00841	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00297	0.00782	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Orlistat—obesity	0.00293	0.00772	CcSEcCtD
Azilsartan medoxomil—Fatigue—Orlistat—obesity	0.00293	0.00771	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Sibutramine—obesity	0.00284	0.00747	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Bupropion—obesity	0.00281	0.0074	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Bupropion—obesity	0.00278	0.00733	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Topiramate—obesity	0.00253	0.00667	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Topiramate—obesity	0.00253	0.00665	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Bupropion—obesity	0.00247	0.00652	CcSEcCtD
Azilsartan medoxomil—Fatigue—Bupropion—obesity	0.00247	0.00651	CcSEcCtD
Azilsartan medoxomil—Asthenia—Orlistat—obesity	0.00244	0.00642	CcSEcCtD
Azilsartan medoxomil—Pruritus—Orlistat—obesity	0.0024	0.00633	CcSEcCtD
Azilsartan medoxomil—Losartan—ACE—obesity	0.00237	0.285	CrCbGaD
Azilsartan medoxomil—Asthenia—Sibutramine—obesity	0.00236	0.00621	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Topiramate—obesity	0.00233	0.00614	CcSEcCtD
Azilsartan medoxomil—Pruritus—Sibutramine—obesity	0.00233	0.00612	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Orlistat—obesity	0.00232	0.00612	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Sibutramine—obesity	0.00225	0.00592	CcSEcCtD
Azilsartan medoxomil—Dizziness—Orlistat—obesity	0.00225	0.00592	CcSEcCtD
Azilsartan medoxomil—Dizziness—Sibutramine—obesity	0.00217	0.00572	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Topiramate—obesity	0.00215	0.00566	CcSEcCtD
Azilsartan medoxomil—Rash—Orlistat—obesity	0.00214	0.00564	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Orlistat—obesity	0.00214	0.00563	CcSEcCtD
Azilsartan medoxomil—Rash—Sibutramine—obesity	0.00207	0.00546	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Sibutramine—obesity	0.00207	0.00545	CcSEcCtD
Azilsartan medoxomil—Asthenia—Bupropion—obesity	0.00206	0.00541	CcSEcCtD
Azilsartan medoxomil—Pruritus—Bupropion—obesity	0.00203	0.00534	CcSEcCtD
Azilsartan medoxomil—Nausea—Orlistat—obesity	0.00202	0.00531	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Bupropion—obesity	0.00196	0.00516	CcSEcCtD
Azilsartan medoxomil—Nausea—Sibutramine—obesity	0.00195	0.00514	CcSEcCtD
Azilsartan medoxomil—Dizziness—Bupropion—obesity	0.0019	0.00499	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.00189	0.00498	CcSEcCtD
Azilsartan medoxomil—Rash—Bupropion—obesity	0.00181	0.00476	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Bupropion—obesity	0.00181	0.00475	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Topiramate—obesity	0.00179	0.00472	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Topiramate—obesity	0.00177	0.00467	CcSEcCtD
Azilsartan medoxomil—Nausea—Bupropion—obesity	0.0017	0.00448	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Topiramate—obesity	0.00158	0.00415	CcSEcCtD
Azilsartan medoxomil—Fatigue—Topiramate—obesity	0.00157	0.00415	CcSEcCtD
Azilsartan medoxomil—Asthenia—Topiramate—obesity	0.00131	0.00345	CcSEcCtD
Azilsartan medoxomil—Pruritus—Topiramate—obesity	0.00129	0.0034	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Topiramate—obesity	0.00125	0.00329	CcSEcCtD
Azilsartan medoxomil—Dizziness—Topiramate—obesity	0.00121	0.00318	CcSEcCtD
Azilsartan medoxomil—Rash—Topiramate—obesity	0.00115	0.00303	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Topiramate—obesity	0.00115	0.00303	CcSEcCtD
Azilsartan medoxomil—Nausea—Topiramate—obesity	0.00108	0.00286	CcSEcCtD
Azilsartan medoxomil—Losartan—ALB—obesity	0.000972	0.117	CrCbGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—obesity	0.000908	0.00148	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—obesity	0.000899	0.00147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	0.000898	0.00147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KIF7—obesity	0.000892	0.00146	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MKS1—obesity	0.000892	0.00146	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPS—obesity	0.000888	0.00145	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—MC3R—obesity	0.000874	0.00143	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—MC4R—obesity	0.000874	0.00143	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPY1R—obesity	0.000874	0.00143	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPY2R—obesity	0.000874	0.00143	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR2C—obesity	0.000871	0.00142	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—DRD1—obesity	0.000871	0.00142	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PPY—obesity	0.000857	0.0014	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—ADRB1—obesity	0.000844	0.00138	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PRKCH—obesity	0.000841	0.00137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GIP—obesity	0.000841	0.00137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—POMC—obesity	0.000835	0.00137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—obesity	0.000831	0.00136	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NMU—obesity	0.000828	0.00135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPY5R—obesity	0.000828	0.00135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HCRT—obesity	0.000828	0.00135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PMCH—obesity	0.000828	0.00135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GHRL—obesity	0.000826	0.00135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—obesity	0.000819	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—DRD4—obesity	0.000819	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL2—obesity	0.000817	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRLH—obesity	0.000816	0.00133	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	0.000796	0.0013	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPY2R—obesity	0.000794	0.0013	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—MC4R—obesity	0.000794	0.0013	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPY1R—obesity	0.000794	0.0013	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—MC3R—obesity	0.000794	0.0013	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CNR1—obesity	0.000782	0.00128	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PPY—obesity	0.000778	0.00127	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PRKCH—obesity	0.000764	0.00125	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GIP—obesity	0.000764	0.00125	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—DRD2—obesity	0.000763	0.00125	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GCG—obesity	0.000755	0.00123	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—PIK3R1—obesity	0.000738	0.00121	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADRB3—obesity	0.000715	0.00117	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	0.000702	0.00115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—obesity	0.000701	0.00115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GAL—obesity	0.000699	0.00114	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C5AR1—obesity	0.000691	0.00113	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—ADRB2—obesity	0.000684	0.00112	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NMB—obesity	0.000676	0.00111	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GHRH—obesity	0.000676	0.00111	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—obesity	0.000672	0.0011	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	0.000666	0.00109	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—obesity	0.00066	0.00108	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GNB3—obesity	0.000651	0.00106	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADRB3—obesity	0.00065	0.00106	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FFAR4—obesity	0.000645	0.00105	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GAL—obesity	0.000634	0.00104	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GNAS—obesity	0.000634	0.00104	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCK—obesity	0.000632	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C5AR1—obesity	0.000627	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GHSR—obesity	0.000619	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BRS3—obesity	0.000619	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MCHR1—obesity	0.000619	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GLP1R—obesity	0.000616	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—obesity	0.000615	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL5—obesity	0.000606	0.00099	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCKAR—obesity	0.000606	0.00099	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HRH3—obesity	0.000606	0.00099	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SH2B1—obesity	0.000575	0.00094	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GH1—obesity	0.000575	0.00094	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRLHR—obesity	0.000575	0.00094	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCK—obesity	0.000574	0.000938	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	0.00056	0.000916	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GLP1R—obesity	0.000559	0.000914	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HRH3—obesity	0.00055	0.000899	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCKAR—obesity	0.00055	0.000899	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPY—obesity	0.000549	0.000897	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	0.000548	0.000896	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IAPP—obesity	0.000545	0.000891	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APLN—obesity	0.000541	0.000884	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PYY—obesity	0.000541	0.000884	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR2A—obesity	0.000534	0.000873	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—C3—obesity	0.000534	0.000872	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PRKAR2B—obesity	0.00053	0.000865	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR1B—obesity	0.000529	0.000865	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CRH—obesity	0.000529	0.000865	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PNLIP—obesity	0.000513	0.000838	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—AGT—obesity	0.000507	0.000829	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPS—obesity	0.000502	0.00082	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SDC3—obesity	0.0005	0.000818	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPY—obesity	0.000498	0.000814	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IAPP—obesity	0.000495	0.000809	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR2C—obesity	0.000492	0.000804	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—DRD1—obesity	0.000492	0.000804	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NMU—obesity	0.000489	0.000799	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY5R—obesity	0.000489	0.000799	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HCRT—obesity	0.000489	0.000799	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PMCH—obesity	0.000489	0.000799	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR1B—obesity	0.000481	0.000786	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CRH—obesity	0.000481	0.000786	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADRB1—obesity	0.000477	0.000779	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY1R—obesity	0.000469	0.000766	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY2R—obesity	0.000469	0.000766	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MC4R—obesity	0.000469	0.000766	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MC3R—obesity	0.000469	0.000766	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—F2—obesity	0.000468	0.000766	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GHRL—obesity	0.000467	0.000763	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—DRD4—obesity	0.000463	0.000756	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PPY—obesity	0.00046	0.000751	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPS—obesity	0.000456	0.000745	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKCH—obesity	0.000451	0.000738	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HDAC8—obesity	0.000451	0.000738	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GIP—obesity	0.000451	0.000738	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR2C—obesity	0.000447	0.000731	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—DRD1—obesity	0.000447	0.000731	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CNR1—obesity	0.000442	0.000722	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADRB1—obesity	0.000433	0.000707	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—DRD2—obesity	0.000431	0.000705	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LEPR—obesity	0.000429	0.000701	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GCG—obesity	0.000427	0.000697	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—POMC—obesity	0.000427	0.000697	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GHRL—obesity	0.000424	0.000693	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—DRD4—obesity	0.00042	0.000687	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL2—obesity	0.000418	0.000682	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—PIK3CA—obesity	0.000415	0.000679	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CNR1—obesity	0.000401	0.000656	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—DRD2—obesity	0.000392	0.00064	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GCG—obesity	0.000388	0.000633	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADRB2—obesity	0.000386	0.000631	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADRB3—obesity	0.000384	0.000627	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GAL—obesity	0.000375	0.000612	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	0.000371	0.000607	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C5AR1—obesity	0.000371	0.000606	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GNB3—obesity	0.000368	0.000601	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GNAS—obesity	0.000358	0.000585	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADRB2—obesity	0.000351	0.000573	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCL5—obesity	0.000343	0.00056	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCK—obesity	0.000339	0.000554	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKG1—obesity	0.000339	0.000554	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GNB3—obesity	0.000334	0.000546	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RBP4—obesity	0.00033	0.00054	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GLP1R—obesity	0.00033	0.00054	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	0.000329	0.000537	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GNAS—obesity	0.000325	0.000532	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HRH3—obesity	0.000325	0.000531	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCKAR—obesity	0.000325	0.000531	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKAR2B—obesity	0.000313	0.000511	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL5—obesity	0.000311	0.000508	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PRKCD—obesity	0.000309	0.000504	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NCF2—obesity	0.000302	0.000494	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR2A—obesity	0.000302	0.000493	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C3—obesity	0.000302	0.000493	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY—obesity	0.000294	0.000481	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOC3—obesity	0.000293	0.000478	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IAPP—obesity	0.000293	0.000478	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AGT—obesity	0.000287	0.000468	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CRH—obesity	0.000284	0.000464	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR1B—obesity	0.000284	0.000464	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SDC1—obesity	0.000281	0.000459	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PRKCD—obesity	0.00028	0.000458	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKR1C3—obesity	0.000276	0.000452	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR2A—obesity	0.000274	0.000448	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C3—obesity	0.000274	0.000448	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPS—obesity	0.000269	0.00044	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—F2—obesity	0.000265	0.000433	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PRKCB—obesity	0.000265	0.000433	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DRD1—obesity	0.000264	0.000432	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR2C—obesity	0.000264	0.000432	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AGT—obesity	0.00026	0.000425	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTRK2—obesity	0.000257	0.00042	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADRB1—obesity	0.000256	0.000418	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3CG—obesity	0.000253	0.000414	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PARP1—obesity	0.00025	0.000409	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GHRL—obesity	0.00025	0.000409	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DRD4—obesity	0.000248	0.000406	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—POMC—obesity	0.000241	0.000394	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—F2—obesity	0.00024	0.000393	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PRKCB—obesity	0.00024	0.000393	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CNR1—obesity	0.000237	0.000387	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TCF7L2—obesity	0.000233	0.000381	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AKT2—obesity	0.000232	0.000379	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DRD2—obesity	0.000231	0.000378	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3CG—obesity	0.00023	0.000376	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GCG—obesity	0.000229	0.000374	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTPN1—obesity	0.000229	0.000374	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3CD—obesity	0.000223	0.000364	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—POMC—obesity	0.000219	0.000358	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRL—obesity	0.000218	0.000357	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—STK11—obesity	0.000215	0.000352	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL2—obesity	0.000214	0.00035	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLG—obesity	0.000213	0.000348	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—RHOA—obesity	0.000213	0.000347	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AKT2—obesity	0.000211	0.000344	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3R1—obesity	0.00021	0.000344	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FOXO3—obesity	0.000208	0.00034	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADRB2—obesity	0.000207	0.000339	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SOCS1—obesity	0.000204	0.000333	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3CD—obesity	0.000202	0.000331	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SOCS3—obesity	0.000202	0.000329	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GNB3—obesity	0.000197	0.000322	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TYK2—obesity	0.000195	0.000318	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3CB—obesity	0.000194	0.000317	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IGF2—obesity	0.000194	0.000317	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—RHOA—obesity	0.000193	0.000315	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GNAS—obesity	0.000192	0.000314	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3R1—obesity	0.000191	0.000312	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOB—obesity	0.000188	0.000307	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL5—obesity	0.000184	0.0003	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LPL—obesity	0.00018	0.000294	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FOXO1—obesity	0.000178	0.000291	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RPS6KB1—obesity	0.000178	0.000291	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3CB—obesity	0.000176	0.000288	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKCD—obesity	0.000166	0.000271	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR2A—obesity	0.000162	0.000265	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C3—obesity	0.000162	0.000264	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IRS2—obesity	0.000154	0.000251	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AGT—obesity	0.000154	0.000251	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LEP—obesity	0.000151	0.000246	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOE—obesity	0.000151	0.000246	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CAV1—obesity	0.000149	0.000244	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOA1—obesity	0.000149	0.000243	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ESR1—obesity	0.000144	0.000235	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKCB—obesity	0.000142	0.000232	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—F2—obesity	0.000142	0.000232	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BAD—obesity	0.00014	0.000229	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3CG—obesity	0.000136	0.000222	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IRS1—obesity	0.000134	0.00022	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—POMC—obesity	0.000129	0.000211	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—INS—obesity	0.000129	0.00021	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL2—obesity	0.000127	0.000207	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IGF1—obesity	0.000124	0.000203	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKT2—obesity	0.000124	0.000203	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3CD—obesity	0.000119	0.000195	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3CA—obesity	0.000118	0.000193	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SERPINE1—obesity	0.000118	0.000193	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TYK2—obesity	0.000115	0.000188	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RHOA—obesity	0.000114	0.000186	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3R1—obesity	0.000113	0.000184	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOS3—obesity	0.000113	0.000184	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3CA—obesity	0.000107	0.000176	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MTOR—obesity	0.000104	0.00017	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3CB—obesity	0.000104	0.00017	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AKT1—obesity	9.67e-05	0.000158	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6—obesity	9.52e-05	0.000156	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP9—obesity	9.05e-05	0.000148	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MAPK8—obesity	8.8e-05	0.000144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AKT1—obesity	8.78e-05	0.000143	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—STAT3—obesity	8.05e-05	0.000132	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MYC—obesity	7.48e-05	0.000122	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TGFB1—obesity	7.46e-05	0.000122	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3CA—obesity	6.35e-05	0.000104	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6—obesity	5.62e-05	9.19e-05	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKT1—obesity	5.19e-05	8.48e-05	CbGpPWpGaD
